World Heart Failure Drugs Market to Witness a CAGR of 9.1% During 2019-2025 - Dominated by Novartis, GlaxoSmithKline, AstraZeneca, Bayer, and Pfizer - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 30, 2019--
DUBLIN--(BUSINESS WIRE)--May 30, 2019--